CM
AXNX

Crystalline Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Crystalline Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$696K Sell
10,000
-20,000
-67% -$1.37M 0.62% 35
2024
Q2 		$2.02M Sell
30,000
-3,588
-11% -$242K 1.92% 17
2024
Q1 		$2.32M Buy
+33,588
New +$2.27M 3.02% 9

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Crystalline Management's AXNX Position: Q3 2024 in Review

Crystalline Management reduced its Axonics, Inc. Common Stock (AXNX) stake by 67% in Q3 2024, selling an estimated $1.37M and leaving 10,000 shares worth $696K. The position accounts for 0.62% of the portfolio, ranked #35.

Crystalline Management first reported a position in AXNX in Q1 2024 and has held it in 3 quarters since. The position peaked at $2.32M in Q1 2024. 233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Crystalline Management held 10,000 shares of Axonics, Inc. Common Stock worth $696K as of Q3 2024.
  • Crystalline Management sold 20,000 Axonics, Inc. Common Stock shares in Q3 2024, an estimated $1.37M.
  • Axonics, Inc. Common Stock made up 0.62% of Crystalline Management's portfolio in Q3 2024, its #35 holding.
  • Crystalline Management first reported a position in Axonics, Inc. Common Stock in Q1 2024 and has held it in 3 quarters since.
  • Crystalline Management's Axonics, Inc. Common Stock position peaked at $2.32M in Q1 2024.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Crystalline Management's 13F filing for Q3 2024, filed 8 Nov 2024.